LLY Stock Hits New Record, Eli Lilly Valuation Pushes Past Berkshire Hathaway Ahead Of Q3 Earnings
According to The Fly, Goldman Sachs expects Lilly to beat Q3 earnings estimates and raise its outlook, citing stronger-than-expected Mounjaro growth outside the U.S. and Zepbound volume gains supported by Medicare’s GLP-1 Bridge program.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
